Top Markets
Coin of the day
Gencurix, Inc. Gencurix, Inc.

Gencurix, Inc.

229000
Rank in Stocks #28133
Gencurix Inc. provides diagnostic solutions in South Korea. Its products... Gencurix Inc. provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection. The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform. The company was founded in 2011 and is headquartered in Seoul, South Korea.
Share Price
$1.21
Market Cap
$28.43M
Change (1 day)
1.27%
Change (1 year)
6.29%
Country
KR
Trade Gencurix, Inc. (229000)

Category

Earnings for Gencurix, Inc. (229000)
Earnings in 2026 TTM: 0
According to Gencurix, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Gencurix, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors